1-(5-Cyanopyridin-2-yl)piperidine-4-carboxylic acid

Catalog No. :
ACHYRA196
CAS No. :
162997-28-6
Molecular Formula :
C12H13N3O2
Molecular Weight :
231.26

IUPAC Name:1-(5-cyanopyridin-2-yl)piperidine-4-carboxylic acid

1-(5-Cyanopyridin-2-yl)piperidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$97.00Login to see priceIn stockInquiry
250mg95%$158.00Login to see priceIn stockInquiry
1g95%$349.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-Cyanopyridin-2-yl)piperidine-4-carboxylic acid
IUPAC Name1-(5-cyanopyridin-2-yl)piperidine-4-carboxylic acid
MDL No.MFCD08691196
Molecular FormulaC12H13N3O2
Molecular Weight231.26
SMILESO=C(C1CCN(C2=NC=C(C#N)C=C2)CC1)O
InChI KeyDKTWMVJYYKLZRD-UHFFFAOYSA-N
Synonym4-Piperidinecarboxylic acid, 1-(5-cyano-2-pyridinyl)-;1-(5-Cyano-2-pyridinyl)-4-piperidinecarboxylic acid;1-(5-Cyano-2-pyridinyl)-4-piperidinecarboxylic acid - [C93548]
CAS No.162997-28-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHYRA196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOSPA207 route compound structure diagram
    ACOSPA207139585-70-9 In Stock
  2. Plus
  3. ACIWFN675 route compound structure diagram
    ACIWFN6755984-56-5 In Stock
  4. Then
  5. ACHYRA196 route product structure diagram
    ACHYRA196162997-28-6 In Stock
Inquiry

2. ACHYRA196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHYRA196 route product structure diagram
    ACHYRA196162997-28-6 In Stock
Inquiry

Comments (0)